Filter Placement (filter + placement)

Distribution by Scientific Domains


Selected Abstracts


NEW BASES FOR PERCUTANEOUS CAVAL FILTER PLACEMENT ON SITE IN GERIATRIC INSTITUTION IN PATIENTS AGED 75 AND OLDER

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Issue 5 2005
Alain F. Le Blanche MD
No abstract is available for this article. [source]


Critical Role of Inferior Vena Caval Filter Placement After Pulmonary Embolectomy

JOURNAL OF CARDIAC SURGERY, Issue 3 2005
Peter Rosenberger M.D.
Postoperative placement of an inferior vena caval filter (IVCF) may prevent recurrent PE. We present a patient who underwent pulmonary embolectomy in whom postoperative placement of an IVCF was postponed due to hemodynamic instability and severe hemorrhage. Recurrent PE was recognized 12 hours after the initial surgery, and required reoperative pulmonary embolectomy. This report documents that recurrent PE can occur early after pulmonary embolectomy even in the presence of coagulopathy. Therefore, concurrent IVCF placement should be considered during or immediately after pulmonary embolectomy to prevent recurrent pulmonary embolism. [source]


Right Axillary Vein Cannulation for Percutaneous Cardiopulmonary Support

ARTIFICIAL ORGANS, Issue 2 2007
Masato Tochii
Abstract:, A 34-year-old male with a past history of permanent inferior vena cava (IVC) filter placement was referred to us for chronic thromboembolic pulmonary hypertension. Percutaneous cardiopulmonary support (PCPS) was required for the lung hemorrhage and reperfusion injury, although the thromboendarterectomy was successfully completed. The arterial cannula was inserted into the femoral artery, and the venous cannula was inserted into the right axillary vein. The patient was weaned from PCPS 1 day after the operation and was discharged 35 days after the operation. Axillary vein cannulation is thought to be a feasible method when PCPS is required for a patient with previous IVC filter placement. [source]


Percutaneous rheolytic thrombectomy for large pulmonary embolism: A promising treatment option

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Issue 1 2007
Manish S. Chauhan MD
Abstract Background: Pulmonary embolism (PE) is a common cardiovascular disease with significant mortality. Some patients with large PE are not eligible for current treatment options such as thrombolysis or surgical embolectomy. We report our experience of percutaneous rheolytic thrombectomy (PRT) using the AngioJet system combined with adjunctive local thrombolytic therapy and inferior vena cava (IVC) filter placement to treat massive or submassive PE in patients ineligible for current treatment options. Methods and Results: Of the 14 consecutive patients ineligible for thrombolysis or embolectomy treated with PRT, 10 patients had massive PE (6 patients were hypotensive and 4 patients had intractable hypoxemia) and 4 patients had submassive PE. Adjunctive local thrombolysis was performed in 5 patients. An IVC filter was placed in 11 patients. Angiographic success based on Miller score was achieved in 13 patients (92.9%). Procedure success was obtained in 12 patients (85.7%). Procedural mortality occurred in one patient who presented in cardiogenic shock (7.1%) and non-fatal hemoptysis occurred in 1 patient (7.1%). Total in-hospital mortality occurred in 3 patients (21.4%). On a mean follow-up of 9 months, all 11 survivors had noted significant improvement in symptoms without recurrence. Conclusions: Percutaneous rheolytic thrombectomy using the AngioJet may be a treatment option for patients with massive or submassive PE who may not be eligible for thrombolytic therapy or surgical embolectomy. © 2007 Wiley-Liss, Inc. [source]